Trials / Completed

CompletedNCT00302640

Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children

Multi-center, Double-blind, Placebo-controlled Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children

Status: Completed
Phase: Phase 2 / Phase 3
Study type: Interventional
Enrollment: 50 (actual)

Sponsor: Romark Laboratories L.C. · Industry
Sex: All
Age: 11 Years
Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine the effect of nitazoxanide suspension in treating diarrhea caused by enteric viruses in children less than 12 years of age.

Conditions

Rotavirus Infection
Adenoviridae Infection
Norovirus Infection

Interventions

Type	Name	Description
DRUG	Alinia (nitazoxanide)

Timeline

Start date: 2005-02-01
Completion: 2005-09-01
First posted: 2006-03-14
Last updated: 2012-05-31

Source: ClinicalTrials.gov record NCT00302640. Inclusion in this directory is not an endorsement.